Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides…
FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es
FDA Announces Availability of Draft Guidance – Drug Master Files — Read on s2027422842.t.en25.com/e/es
The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine…
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides…
The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name…
New Study Points to Targetable Protective Factor in Alzheimer’s Disease – NIH Director’s Blog — Read on directorsblog.nih.gov/2019/09/10/new-study-points-to-targetable-protective-factor-in-alzheimers-disease/
The effect of oral androgen signaling inhibitor therapies on patients with pre-existing cardiovascular disease may increase the risk of death.…
The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications. — Read on…
The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications. — Read on…